awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37494640-2B0DDF0E-D29B-48EA-A992-92F6B1AEB401
Q37494640-2B0DDF0E-D29B-48EA-A992-92F6B1AEB401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494640-2B0DDF0E-D29B-48EA-A992-92F6B1AEB401
Application of mechanism-based CYP inhibition for predicting drug-drug interactions.
P2860
Q37494640-2B0DDF0E-D29B-48EA-A992-92F6B1AEB401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494640-2B0DDF0E-D29B-48EA-A992-92F6B1AEB401
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21303bd802f73187b46d665a9d748b9656461faf
P2860
The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.